UBS Group AG - VIRPAX PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 16 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$94
-98.7%
118
-99.0%
0.00%–
Q4 2022$7,346
+4.9%
11,849
+88.2%
0.00%–
Q3 2022$7,000
-82.1%
6,296
-44.7%
0.00%–
Q4 2021$39,000
+116.7%
11,385
+188.8%
0.00%–
Q2 2021$18,000
+28.6%
3,942
+32.3%
0.00%–
Q1 2021$14,000–2,980–0.00%–
 Download
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 292,790$234,2030.17%
OSAIC HOLDINGS, INC. 600$4790.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$80,7000.00%
WELLS FARGO & COMPANY/MN 63$500.00%
NORTHERN TRUST CORP 15,221$12,1750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 63,928$51,1700.00%
MORGAN STANLEY 150$1200.00%
BlackRock Inc. 464$3710.00%
Tower Research Capital LLC (TRC) 6,220$4,9760.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders